Radavirsen

DB15332InvestigationalGene Therapies

Radavirsen is under investigation in clinical trial NCT01375985 (Safety Study of Single Administration Intravenous Treatment for Influenza).

Code names
AVI-7100

Resolves to

Compound
UNII9P30PF804HCAS1228284-45-4

What you can answer from here — as of April 23, 2025

14Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Radavirsen, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In